Last reviewed · How we verify

paracetamol codein — Competitive Intelligence Brief

paracetamol codein (paracetamol codein) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Analgesic combination (paracetamol + opioid). Area: Pain management.

marketed Analgesic combination (paracetamol + opioid) COX enzymes (paracetamol); mu opioid receptor (codeine) Pain management Small molecule Live · refreshed every 30 min

Target snapshot

paracetamol codein (paracetamol codein) — Diskapi Yildirim Beyazit Education and Research Hospital. Paracetamol reduces fever and pain through inhibition of prostaglandin synthesis, while codeine acts as an opioid agonist to enhance analgesia.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
paracetamol codein TARGET paracetamol codein Diskapi Yildirim Beyazit Education and Research Hospital marketed Analgesic combination (paracetamol + opioid) COX enzymes (paracetamol); mu opioid receptor (codeine)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Analgesic combination (paracetamol + opioid) class)

  1. Diskapi Yildirim Beyazit Education and Research Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). paracetamol codein — Competitive Intelligence Brief. https://druglandscape.com/ci/paracetamol-codein. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: